Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
Home
ETF
LTRN
LTRN
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
LTRN News
Lantern Pharma Reports Reduced Q4 Net Loss
16h ago
seekingalpha
Lantern Pharma Receives FDA IND Approval for STAR-001
1d ago
NASDAQ.COM
Lantern Pharma Q4 2025 Earnings Call Insights
12h ago
seekingalpha
PMGC Holdings Unit Amends Clinical Trial Agreement
1d ago
stocktwits
Leading Pre-Market Gainers Today — ELAB, ITRM, LTRN Among Stocks Rising Ahead of Market Open
1d ago
stocktwits
Lantern Pharma CEO Panna Sharma Remains in Position, Addresses False Claims
3d ago
Newsfilter
LANTERN PHARMA AFFIRMS PANNA SHARMA REMAINS PRESIDENT AND CEO; WARNS INVESTORS ABOUT INACCURATE THIRD-PARTY REPORT
3d ago
moomoo
Lantern Pharma Receives FDA Clearance for STAR-001 Pediatric Trial
3d ago
NASDAQ.COM
LANTERN PHARMA STOCK RISES 7.1% FOLLOWING FDA APPROVAL FOR CHILD BRAIN CANCER TREATMENT TRIAL
3d ago
moomoo
Lantern Pharma Receives FDA IND Approval for STAR-001
3d ago
stocktwits
FDA Approves STAR-001 for Pediatric CNS Cancer Trial
4d ago
Newsfilter
RedChip Releases AI Investor Conference Replays
4d ago
Yahoo Finance
Lantern Pharma to Host Q4 2025 Earnings Webcast on March 30
Mar 23 2026
Newsfilter
Growth Prospects for the EGFR-NSCLC Market Analyzed
Feb 11 2026
Newsfilter
Lantern Pharma CEO to Present at Glioblastoma Summit
Feb 10 2026
Businesswire
New to The Street Highlights Blockchain and Oncology Innovations in Episode #710
Dec 27 2025
Yahoo Finance
Show More News
